SFX by Ex Libris Inc.

Title:	Protein kinase inhibitors: insights into drug design from structure
Source:	Science [0036-8075] Noble, M E yr:2004

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Phatak, P. "Telomerase and its potential for therapeutic intervention." British journal of pharmacology 152.7 (2008): 1003-11.
description	2.	Manning, G. "The Protein Kinase Complement of the Human Genome." Science 298.5600 (2002): 1912-34.
description	3.	Helleday, T. "DNA repair pathways as targets for cancer therapy." Nature reviews. Cancer 8.3 (2008): 193-204.
description	4.	Johnson, L. "Active and inactive protein kinases: Structural basis for regulation." Cell 85.2: 149-158.
description	5.	Cohen, P. "Protein kinases--the major drug targets of the twenty-first century?" Nature reviews. Drug discovery 1.4 (2002): 309-15.
description	6.	Guchelaar, H J J. "Clinical, toxicological and pharmacological aspects of gemcitabine." Cancer Treatment Reviews 22.1 (1996): 15-31.
description	7.	Curtin, N J J. "The role of PARP in DNA repair and its therapeutic exploitation." British Journal of Cancer 105.8 (2011): 1114-1122.
description	8.	Mitchell, S J J. "Glutamate spillover suppresses inhibition by activating presynaptic mGluRs." Nature 404.6777 (2000): 498-502.
description	9.	Hurley, Laurence H H. "DNA and its associated processes as targets for cancer therapy." Nature reviews. Cancer 2.3 (2002): 188-200.
description	10.	Bicknell, R. "Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy." Trends in pharmacological sciences 16.2: 57-66.
description	11.	Knowles, J. "A guide to drug discovery: Target selection in drug discovery." Nature reviews. Drug discovery 2.1 (2002): 63-9.
description	12.	Manning, G.. "Evolution of protein kinase signaling from yeast to man." Trends in biochemical sciences 27.10 (2002): 514-520.
description	13.	Branzei, D. "Regulation of DNA repair throughout the cell cycle." Nature reviews. Molecular cell biology 9.4 (2008): 297-308.
description	14.	KNIGHTON, D. "STRUCTURE OF A PEPTIDE INHIBITOR BOUND TO THE CATALYTIC SUBUNIT OF CYCLIC ADENOSINE-MONOPHOSPHATE DEPENDENT PROTEIN-KINASE." Science 253.5018 (1991): 414-420.
description	15.	Helleday, T. "DNA double-strand break repair: From mechanistic understanding to cancer treatment." DNA repair 6.7 (2007): 923-935.
description	16.	Jordan, Leslie A. "Microtubules as a target for anticancer drugs." Nature reviews. Cancer 4.4 (2004): 253-265.
description	17.	HANKS, S. "PROTEIN KINASES .6. THE EUKARYOTIC PROTEIN-KINASE SUPERFAMILY - KINASE (CATALYTIC) DOMAIN-STRUCTURE AND CLASSIFICATION." The FASEB journal 9.8 (1995): 576-596.
description	18.	Johnson, Sam A. "Kinomics: methods for deciphering the kinome." Nature methods 2.1 (2005): 17-25.
description	19.	Knighton, D R R. "Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase." Science 253.5018 (1991): 407-14.
description	20.	Rao, V V V. "Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier." Proceedings of the National Academy of Sciences of the United States of America 96.7 (1999): 3900-3905.